@RadOncPapers

Bot serving up piping hot auto-feed of RADIATION ONCOLOGY manuscripts/pre-prints from PubMed/IEEE Xplore/arxiv/biorxiv/medrxiv. Managed (badly) by @cd_fuller

[@RadOncPapers @radoncpapers]

This #radonc litbot searches MeSH terms/keywords for “radiotherapy” and “radiation oncology” from common manuscript/preprint repositories for your leisure reading :)

H/T @caseybergman & @RobLanfear https://t.co/bWL3nh8oUL

[@RadOncPapers @radoncpapers]

Polymorphous adenocarcinoma of salivary glands. https://t.co/VswSzlgsQW H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Prognostic determinants of locally advanced buccal mucosa cancer: Do we need to relook the current staging criteria? https://t.co/1XF5VOjkq4 H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data. https://t.co/wkCm329lf0 H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

The prognostic value of CT-based image-biomarkers for head and neck cancer patients treated with definitive (chemo-)radiation. https://t.co/28KJhgleiO H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trial. https://t.co/dK0GXKawgO H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Induction chemotherapy in head and neck cancers: Results and controversies. https://t.co/dZGQe1ipTk H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Radiation Biomarkers: Can Small Businesses Drive Accurate Radiation Precision Medicine? https://t.co/xp6LMV6TxZ H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Delivery and Effectiveness of Carboplatin via Targeted Delivery Compared to Passive Accumulation of Intravenously Injected Particles Releasing Carboplatin upon Irradiation. https://t.co/yw8UtiYhby H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation. https://t.co/lQDFFYYJFD H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Pet Dogs with Subclinical Acute Radiodermatitis Experience Widespread Somatosensory Sensitization. https://t.co/Prdlck3hxC H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Automatic detection of brachytherapy seeds in 3D ultrasound images using a convolutional neural network. https://t.co/siyuabv5ci H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Craniopharyngioma. https://t.co/rOPiKqQrZD H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Treatment of Differentiated Thyroid Carcinomas. https://t.co/PpCoGdPrcC H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial. https://t.co/Hi1lSOG2JG H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. https://t.co/ysTYjTi8c9 H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial. https://t.co/E3G5drt8ZE H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Head and neck squamous cell cancer associated with lymphoproliferative malignancies is aggressive. https://t.co/e87fuTiWBC H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling. https://t.co/Fp5OlIZqC4 H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

The Authors Reply. https://t.co/q60PwOYO8L H/T @NCBI #radonc #PubMed

[@RadOncPapers @radoncpapers]

Is Lateral Lymph Node Dissection Necessary for Node Size https://t.co/cXpsebABob H/T @NCBI #radonc #PubMed